MedPath
FDA Approval

Ozempic

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Novo Nordisk
DUNS: 622920320
Effective Date
September 22, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Semaglutide(1.34 mg in 1 mL)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Novo Nordisk Pharmaceutical Industries, LP

Novo Nordisk

622920320

Novo Nordisk A/S

Novo Nordisk

305914798

Products5

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ozempic

Product Details

NDC Product Code
0169-4130
Application Number
NDA209637
Marketing Category
NDA (C73594)
Route of Administration
SUBCUTANEOUS
Effective Date
September 22, 2023
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACTQuantity: 14.0 mg in 1 mL
PHENOLInactive
Code: 339NCG44TVClass: IACTQuantity: 5.50 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: 53AXN4NNHXClass: ACTIBQuantity: 1.34 mg in 1 mL
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Code: 94255I6E2TClass: IACTQuantity: 1.42 mg in 1 mL

Ozempic

Product Details

NDC Product Code
0169-4772
Application Number
NDA209637
Marketing Category
NDA (C73594)
Route of Administration
SUBCUTANEOUS
Effective Date
September 22, 2023
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Code: 94255I6E2TClass: IACTQuantity: 1.42 mg in 1 mL
PHENOLInactive
Code: 339NCG44TVClass: IACTQuantity: 5.50 mg in 1 mL
Code: 53AXN4NNHXClass: ACTIBQuantity: 2.68 mg in 1 mL
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACTQuantity: 14.0 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT

Ozempic

Product Details

NDC Product Code
0169-4181
Application Number
NDA209637
Marketing Category
NDA (C73594)
Route of Administration
SUBCUTANEOUS
Effective Date
September 22, 2023
Code: 53AXN4NNHXClass: ACTIBQuantity: 0.68 mg in 1 mL
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Code: 94255I6E2TClass: IACTQuantity: 1.42 mg in 1 mL
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACTQuantity: 14.0 mg in 1 mL
PHENOLInactive
Code: 339NCG44TVClass: IACTQuantity: 5.50 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT

Ozempic

Product Details

NDC Product Code
0169-4132
Application Number
NDA209637
Marketing Category
NDA (C73594)
Route of Administration
SUBCUTANEOUS
Effective Date
September 22, 2023
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Code: 94255I6E2TClass: IACTQuantity: 1.42 mg in 1 mL
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACTQuantity: 14.0 mg in 1 mL
PHENOLInactive
Code: 339NCG44TVClass: IACTQuantity: 5.50 mg in 1 mL
Code: 53AXN4NNHXClass: ACTIBQuantity: 1.34 mg in 1 mL

Ozempic

Product Details

NDC Product Code
0169-4136
Application Number
NDA209637
Marketing Category
NDA (C73594)
Route of Administration
SUBCUTANEOUS
Effective Date
September 22, 2023
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: 53AXN4NNHXClass: ACTIBQuantity: 1.34 mg in 1 mL
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACTQuantity: 14.0 mg in 1 mL
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Code: 94255I6E2TClass: IACTQuantity: 1.42 mg in 1 mL
PHENOLInactive
Code: 339NCG44TVClass: IACTQuantity: 5.50 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath